Spots Global Cancer Trial Database for vulvar cancer
Every month we try and update this database with for vulvar cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | NCT02653118 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | V503 GARDASIL | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| MR-HIFU for Recurrent Gynaecological Cancer | NCT02714621 | Cervical Cancer Endometrial Can... Uterine Cancer Ovarian Cancer Vaginal Cancer Vulvar Cancer | Magnetic Resona... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| A Survivorship Care Plan for Gynaecological Cancer Patients | NCT01582906 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
| The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence | NCT01986725 | Vulvar Cancer Vulvar Intraepi... | standardized ca... Standardized ca... | 18 Years - | St.Gallen University of Applied Sciences | |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | NCT02096783 | Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer | informational i... counseling inte... questionnaire a... | 18 Years - | University of Wisconsin, Madison | |
| The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study | NCT04122235 | Gynecologic Can... Gynecologic Neo... Ovarian Cancer Endometrial Can... Cervical Cancer Vulvar Cancer | LETSGO follow-u... | 18 Years - | Sorlandet Hospital HF | |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva | NCT00006096 | Vulvar Cancer | cisplatin radiation thera... | - | GOG Foundation | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT05372016 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | Experimental: E... Active Comparat... | 16 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer | NCT06127836 | Vulvar Cancer | ICG guided sent... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) | NCT06029504 | Vulvar Cancer Sentinel Lymph ... | 18 Years - | Rigshospitalet, Denmark | ||
| A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | NCT00943722 | Cervical Cancer... Vulvar Cancer Vaginal Cancer Genital Lesions PAP Test Abnorm... HPV Infections | V503 | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study | NCT04952961 | Self-Examinatio... Vulvar Cancer Vulvar Lichen S... Vulval Intraepi... Vulval Cancer Vulval Intraepi... Lichen Planus | Training in Vul... | 18 Years - | University of Manchester | |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Tension-free Vaginal Tape (TVT) Versus Bulking Agent for the Treatment of Post Vulvectomy Urinary Incontinence | NCT01148290 | Urinary Inconti... | Tension free va... Bulking agent i... | 18 Years - 95 Years | University Magna Graecia | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| Effectiveness of an Individualized Symptom Education Program (ISEP) | NCT00275353 | Uterine Cancer Cervical Cancer Vaginal Cancer Vulvar Cancer | Individualized ... | 18 Years - | University of Toronto | |
| Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Questionnaire Study for Gynecological Cancer Survivors | NCT00391664 | Endometrial Neo... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Genital Neoplas... | Psychosocial | 20 Years - 75 Years | Walter Reed Army Medical Center | |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT03676101 | Cervical Cancer... Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcin... Mild Dysplasia ... Moderate Dyspla... Vin III VaIN1 VaIN2 VaIN3 Genital Wart | 9-valent HPV Re... Placebo | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer | NCT06292689 | Vulvar and Vagi... | Cardunolizumab | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers | NCT00773071 | Cervical Cancer Vulvar Cancer | SPECT/CT guided... | 18 Years - | Lawson Health Research Institute | |
| Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva | NCT00003325 | Vulvar Cancer | Sentinel lymph ... | - | GOG Foundation | |
| Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers | NCT02003430 | Non-ovarian Gyn... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer | NCT04105465 | Vulvar Cancer Groin Node | PlasmaJet | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China | NCT05662020 | Human Papilloma... | Recombinant Non... GARDASIL® 9 | 9 Years - 26 Years | Beijing Health Guard Biotechnology, Inc | |
| Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) | NCT06029504 | Vulvar Cancer Sentinel Lymph ... | 18 Years - | Rigshospitalet, Denmark | ||
| Tension-free Vaginal Tape (TVT) Versus Bulking Agent for the Treatment of Post Vulvectomy Urinary Incontinence | NCT01148290 | Urinary Inconti... | Tension free va... Bulking agent i... | 18 Years - 95 Years | University Magna Graecia | |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | NCT00520598 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: V50... Comparator: V50... Comparator: V50... Comparator: V50... Comparator: Qua... Comparator: Pla... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer | NCT05255393 | Cervical Cancer Vulvar Cancer | Questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | NCT00381888 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Thromboembolism Vaginal Cancer Vulvar Cancer | fondaparinux so... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | NCT00943722 | Cervical Cancer... Vulvar Cancer Vaginal Cancer Genital Lesions PAP Test Abnorm... HPV Infections | V503 | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | NCT00014599 | Vulvar Cancer | paclitaxel | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva | NCT00006096 | Vulvar Cancer | cisplatin radiation thera... | - | GOG Foundation | |
| Evaluation of Robot-Assisted Surgery in Gynecologic Oncology | NCT00671827 | Gynecologic Can... | Questionnaire | - | M.D. Anderson Cancer Center | |
| Serial MRI Scans During Radiation Therapy | NCT04188535 | Glioblastoma Esophageal Canc... Radiotherapy Magnetic Resona... MRI Prostate Cancer Vulvar Cancer Pediatric Gliob... | MRI IMAGING | 18 Years - | Dana-Farber Cancer Institute | |
| STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | NCT05576831 | Vulvar Cancer | Re-excision | 18 Years - | British Columbia Cancer Agency | |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
| Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies | NCT05979610 | Gynecologic Neo... Brachytherapy Therapeutic Tou... Endometrial Can... Cervical Cancer Vaginal Cancer Vulvar Cancer | Reiki therapy | 18 Years - | University of Utah | |
| Serial MRI Scans During Radiation Therapy | NCT04188535 | Glioblastoma Esophageal Canc... Radiotherapy Magnetic Resona... MRI Prostate Cancer Vulvar Cancer Pediatric Gliob... | MRI IMAGING | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
| Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | NCT00905658 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | therapeutic nut... standard follow... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. | NCT03061435 | Vulvar Cancer Cervical Cancer Vulvar Dysplasi... Cervical Dyspla... Anal Cancer Anal Dysplasia HPV-Related Ana... | Screening anal ... Screening anal ... | 40 Years - | Sunnybrook Health Sciences Centre | |
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors | NCT05949632 | Advanced Solid ... | INCB099280 axitinib | 18 Years - | Incyte Corporation | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233) | NCT06132321 | Vulvar Neoplasm... | Quality of life... | - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer | NCT06127836 | Vulvar Cancer | ICG guided sent... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) | NCT06029504 | Vulvar Cancer Sentinel Lymph ... | 18 Years - | Rigshospitalet, Denmark | ||
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | NCT04141449 | Neoplasms Hiv Cervical Cancer Breast Cancer HNSCC Vulvar Cancer Anal Cancer Cancer Suspect | Potlako interve... Enhanced care | 30 Years - | Brigham and Women's Hospital | |
| A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) | NCT06023862 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Vulvar Cancer Vagina Neoplasm Clear Cell Carc... | Dostarlimab Bevacizumab Doxorubicin Gemcitabine Paclitaxel Pegylated lipos... | 18 Years - | Yonsei University | |
| Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | NCT03346915 | Human Papilloma... Cervical Cancer Human Papilloma... Oropharyngeal C... Vaginal Cancer Vulvar Cancer Anal Cancer Penile Cancer | WoW and BNI | 9 Years - 65 Years | Boston Medical Center | |
| MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer | NCT06273501 | Vulvar Cancer Lymph Node Meta... | Magtrace | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| Validation of a Nutrition Screening Tool | NCT01851928 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
| Cisplatin+Pembrolizumab+RT in Vulvar Cancer | NCT04430699 | Vulvar Cancer Vulvar Squamous... | Cisplatin Pembrolizumab Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Image-Guided Gynecologic Brachytherapy | NCT02993900 | Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer Bladder Cancer | Image-Guided Br... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT04425291 | Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 4-valent HPV Va... 9-valent HPV Va... GARDASIL® | 20 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Interventions to Decrease Financial Toxicity | NCT05939440 | Cancer, Breast Cancer Colorect... Cancer, Ovarian Cervical Cancer Uterine Cancer Vulvar Cancer | Proactive Cost ... Usual Care | 18 Years - | University of Alabama at Birmingham | |
| Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. | NCT00315159 | Vulvar Cancer | Sentinel Node B... | 18 Years - | Women and Infants Hospital of Rhode Island | |
| A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) | NCT06023862 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Vulvar Cancer Vagina Neoplasm Clear Cell Carc... | Dostarlimab Bevacizumab Doxorubicin Gemcitabine Paclitaxel Pegylated lipos... | 18 Years - | Yonsei University | |
| Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types | NCT05000294 | Bile Duct Cance... Gall Bladder Ca... Breast Cancer Neuroendocrine ... Ovarian Cancer Pancreatic Aden... Soft Tissue Sar... Vulvar Cancer Prostate Cancer | Atezolizumab Tivozanib | 18 Years - 99 Years | University of Florida | |
| Education, Immigration and HPV Vaccination: an Informational Randomized Trial | NCT04905030 | Cervical Cancer Vulvar Cancer Anus Cancer Penis Cancer Mouse Papilloma Head Cancer Genital Wart Neck Cancer | Information T1 Information T2 Information C | - | Karolinska Institutet | |
| Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies | NCT05979610 | Gynecologic Neo... Brachytherapy Therapeutic Tou... Endometrial Can... Cervical Cancer Vaginal Cancer Vulvar Cancer | Reiki therapy | 18 Years - | University of Utah | |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | NCT04895020 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 9-valent HPV va... | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer | NCT06273501 | Vulvar Cancer Lymph Node Meta... | Magtrace | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas | NCT02981862 | Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer | CaptHPV method | 18 Years - | Institut de Cancérologie de Lorraine | |
| Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer | NCT04663412 | Vulvar Cancer | Sentinel lymph ... | 20 Years - 100 Years | Azienda Ospedaliera per l'Emergenza Canizzaro | |
| Vulvar Cancer Individualized Scoring System (VCISS) | NCT06007625 | Vulvar Cancer | Machine learnin... | 18 Years - 80 Years | Assiut University | |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | NCT02628067 | Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc... | pembrolizumab pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies | NCT05914974 | Gynecological M... Cervical Cancer Endometrial Can... Ovarian Cancer Vulvar Cancer | 18 Years - | University Hospital Tuebingen | ||
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | NCT03000192 | Breast Cancer F... Breast Neoplasm Non-Hodgkin's B... Non-Hodgkin's L... NonHodgkin Lymp... Diffuse Large B... Diffuse Large C... Ovarian Cancer Ovarian Neoplas... Endometrial Can... Endometrial Neo... Cervical Cancer Cervical Neopla... Primary Periton... Fallopian Tube ... Fallopian Tube ... Vulvar Cancer Vulvar Neoplasm... | 16 Years - | University Hospital Southampton NHS Foundation Trust | ||
| Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers | NCT02003430 | Non-ovarian Gyn... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | NCT01526486 | Melanoma Merkel Cell Car... Squamous Cell C... Penile Carcinom... Urethral Carcin... Extramammary Pa... Scrotal Carcino... Anal Cancer Vulvar Cancer Skin Cancer Lymphadenopathy | Videoscopic pro... Open, tradition... | 18 Years - 80 Years | Emory University | |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
